Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01E
- Chemical subgroupL01EX
- Chemical substanceL01EX23Pralsetinib
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 1 registration
Spain
AEMPS · 1 registration
European Union
EMA · 1 registration
United States
FDA · 1 registration
At a glance
- ATC code
- L01EX23
- Registers
- 4
- Registrations
- 4
- With their own page
- 1
- Companies
- 3
All medicines with Pralsetinib
Human medicines from every register that match Pralsetinib by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
4 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Gavreto | United States | 100MG | capsule | Marketed | Rigel Pharms |
| Gavreto | European Union | Withdrawn | Blueprint Medicines (Netherlands) B.V. | ||
| Gavreto 100 MG Capsulas Duras | Spain | 100 mg | cápsula dura | Withdrawn | Blueprint Medicines (Netherlands) B.V. |
| Gavreto | Canada | 100 MG | Capsule | Cancelled | Hoffmann-LA Roche Limited |